XML 27 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Stockholders’ Equity
Total Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2021         102,733,273        
Beginning balance at Dec. 31, 2021 $ 689,385   $ 689,385   $ 10 $ 835,694 $ (146,319)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation, net of tax withholding (in shares)         490,910        
Stock-based compensation, net of tax withholding 24,515   24,515   $ 1 24,514      
Issuance of common stock, net of offering costs (in shares)         42,141,733        
Issuance of common stock, net of offering costs 361,486   361,486   $ 4 361,482      
Common stock issued for service and license agreements (in shares)         200,000        
Common stock issued for service and license agreements 4,577   4,577     4,577      
Net income (loss) (694,022)   (694,022)       (694,022)    
Net income (loss) (694,022)                
Ending balance (in shares) at Dec. 31, 2022         145,565,916        
Ending balance at Dec. 31, 2022 $ 385,941 $ 11,483 385,941 $ 11,483 $ 15 1,226,267 (840,341) $ 11,483 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2023-08 [Member]                
Stock-based compensation, net of tax withholding (in shares)         1,269,230        
Stock-based compensation, net of tax withholding $ 32,264   32,264     32,264      
Issuance of common stock, net of offering costs (in shares)         64,271,828        
Issuance of common stock, net of offering costs 608,365   608,365   $ 6 608,359      
Net income (loss) 261,173   261,173       261,173    
Series A preferred stock accretion to redemption value (2,121)   (2,121)     (2,121)      
Exchange of convertible notes for common stock (in shares)         31,722,417        
Exchange of convertible notes for common stock 318,771   318,771   $ 3 318,768      
Other 45   45       45    
Net income (loss) $ 261,173                
Ending balance (in shares) at Dec. 31, 2023 242,829,391       242,829,391        
Ending balance at Dec. 31, 2023 $ 1,615,921   1,615,921   $ 24 2,183,537 (567,640)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation, net of tax withholding (in shares)         5,894,877        
Stock-based compensation, net of tax withholding 155,095   155,095     155,095      
Issuance of common stock, net of offering costs (in shares)         93,411,158        
Issuance of common stock, net of offering costs 1,851,621   1,851,621   $ 10 1,851,611      
Net income (loss) 541,008   541,253       541,253   (245)
Repurchase of shares in settlement of restricted stock (in shares)         (1,876,973)        
Repurchase of shares in settlement of restricted stock (34,857)   (34,857)     (34,857)      
Contribution from noncontrolling interest 7,154               7,154
Net income (loss) $ 541,253                
Ending balance (in shares) at Dec. 31, 2024 340,258,453       340,258,453        
Ending balance at Dec. 31, 2024 $ 4,135,942   $ 4,129,033   $ 34 $ 4,155,386 $ (26,387)   $ 6,909